Sponsor or institution

Clinical trials and research at Sichuan University

• 29Clinical trials
• 1Country

Newest trials

All recruiting trials (29)

• Targeted radiopharmaceutical radiotherapy for relapsed or refractory neuroblastoma

  A short, patient-friendly test of [211At]MABG radiotherapy to see if it is safe and tolerable in kids and young patients with relapsed or hard-to-treat neuroblastoma.

  Recruiting Early Phase 1 Sichuan University · Chengdu, Sichuan · NCT07767630

• Adjuvant sintilimab after neoadjuvant therapy and surgery for high-risk NSCLC

  This trial tests whether giving sintilimab after surgery helps prevent cancer from returning in people with high-risk non-small cell lung cancer who already had neoadjuvant immunochemotherapy and surgery.

  Recruiting at 2 sites Phase 2 Sichuan University · Chengdu, Sichuan and 1 other locations · NCT07748325

• Intensive nutrition during conversion therapy to enable surgery for locally advanced unresectable esophageal squamous cell carcinoma

  This will test whether giving intensive enteral nutrition alongside PD-1 inhibitor plus chemotherapy helps people with locally advanced unresectable esophageal squamous cell carcinoma achieve higher rates of complete tumor removal after conversion therapy.

  Recruiting Phase 2 Sichuan University · Chengdu, Sichuan · NCT07519486

• IR-101 for relapsed or refractory neuroblastoma

  This trial will test whether IR-101, a targeted radiopharmaceutical, can safely treat children (age ≥12 months) and adolescents with relapsed or refractory high-risk neuroblastoma that shows MIBG uptake.

  Recruiting at 2 sites Early Phase 1 Sichuan University · Chengdu, Sichuang and 1 other locations · NCT07067346

• Oncolytic virus plus chemotherapy and PD-1 inhibitor for locally advanced esophageal squamous cell carcinoma

  This trial will try adding an oncolytic virus to chemotherapy and a PD‑1 blocker to see if it helps people with initially unresectable, locally advanced esophageal squamous cell carcinoma become operable and reduce cancer-related events.

  Recruiting Phase 1/2 Sichuan University · Chengdu, Sichuan · NCT07061704

• High-dose gemcitabine, busulfan, and thiotepa with autologous stem cell transplant for primary central nervous system lymphoma.

  This trial tests if giving high-dose gemcitabine, busulfan, and thiotepa before an autologous stem cell transplant is safe and helps control primary CNS lymphoma in adults who are in remission or have a partial response.

  Recruiting Phase 2 Sichuan University · Chengdu, Sichuan · NCT07014943

• mRNA vaccine targeting KRAS-mutated cancers

  We will try an mRNA vaccine that targets KRAS mutations in adults with KRAS-mutated solid tumors, given alone or with the immunotherapy drug toripalimab and/or standard chemotherapy.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT07004244

• Neoadjuvant BL-B01D1 plus Almonertinib for resectable EGFR‑positive stage II–IIIB lung cancer

  This trial will test whether giving BL-B01D1 together with Almonertinib before surgery, followed by Almonertinib after surgery, helps adults with resectable EGFR‑positive stage II–IIIB non‑small cell lung cancer.

  Recruiting Phase 2 Sichuan University · Chengdu, Sichuan · NCT06951464

• Neoadjuvant low-dose radiation and SBRT with tislelizumab plus platinum chemotherapy for stage IIA–IIIB NSCLC

  This test tries to see if giving low-dose radiation and SBRT followed by tislelizumab combined with platinum chemotherapy helps people with stage IIA–IIIB non-small cell lung cancer achieve a complete tumor response before surgery.

  Recruiting Phase 2 Sichuan University · Chengdu, China · NCT06877299

• Improving hypertension self-management in rural patients through doctor-patient interactions

  This study is testing a new way to help people with high blood pressure in rural areas manage their condition better through improved communication with their doctors.

  Recruiting Sichuan University · Chengdu, Sichuan · NCT06869031

• Closing a heart opening to treat drug-resistant epilepsy

  This study is testing if closing a small heart opening can help people with drug-resistant epilepsy have fewer seizures.

  Recruiting Sichuan University · Chengdu, Sichuan · NCT06863350

• Giving prescription glasses to improve vision and thinking in rural older adults

  This project will test whether giving free prescription glasses to rural adults aged 60–79 with correctable vision problems can slow thinking and memory decline over 36 months.

  Recruiting Sichuan University · Ya'an, Sichuan · NCT06836440

• Combining Ivonescimab and Cadonilimab with chemotherapy for extensive stage small cell lung cancer

  This study is testing if combining two new drugs, Ivonescimab and Cadonilimab, with chemotherapy can help people with extensive stage small cell lung cancer feel better compared to standard treatments.

  Recruiting Phase 2 Sichuan University · Chengdu, Sichuan · NCT06769971

• Combining AK112 with chemotherapy for advanced lung cancer

  This study is testing if a new treatment called AK112, when combined with chemotherapy, can help people with advanced lung cancer feel better and improve their health.

  Recruiting Phase 2 Sichuan University · Chengdu, Sichuan · NCT06769295

• Neoantigen vaccines for treating esophageal cancer

  This study is testing a new vaccine for people with advanced esophageal cancer to see if it can help them live longer and feel better after their treatment.

  Recruiting Phase 2 Sichuan University · Chengdu, Please Select · NCT06675201

• Adebrelimab plus chemotherapy with concurrent low-dose radiotherapy for extensive-stage small cell lung cancer

  This trial tests whether adding the immunotherapy adebrelimab to standard chemotherapy together with low-dose radiotherapy helps adults with extensive-stage small cell lung cancer live longer or respond better to treatment.

  Recruiting Phase 2 Sichuan University · Sichuan · NCT06610734

• Combining low-dose radiation with immunochemotherapy for esophageal cancer treatment

  This study is testing whether using low-dose radiation along with chemotherapy and immunotherapy can help improve treatment outcomes for patients with advanced esophageal cancer before surgery.

  Recruiting Phase 2 Sichuan University · Chengdu, Sichuan · NCT06446726

• Combining low dose brain radiotherapy with immunotherapy and intrathecal chemotherapy for lung cancer

  This study is testing a new treatment that combines low dose brain radiation, immune therapy, and chemotherapy to see if it helps people with tough lung cancer that has spread to the brain.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT06431685

• Evaluating a new treatment combining low dose radiotherapy and immunotherapy for bulky tumors

  This study is testing a new treatment that combines low dose radiation and an immunotherapy drug to see if it can help people with large tumors that haven't improved with standard treatments.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT06349837

• Treatment for relapsed small cell lung cancer using CAR-T therapy

  This study is testing a new CAR-T therapy for people with relapsed small cell lung cancer to see if it can help them after other treatments have failed.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT06348797

• Using aromatherapy to reduce anxiety and pain during dental treatments

  This study tests if using sweet orange and tea tree essential oils during dental treatments can help reduce anxiety and pain for adults.

  Recruiting Sichuan University · Chengdu, Sichuan · NCT06347679

• Neoantigen vaccine combined with anti-PD1 and chemotherapy for pancreatic cancer treatment

  This study is testing a new vaccine combined with anti-PD1 therapy and chemotherapy to see if it helps prevent pancreatic cancer from coming back after surgery.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT06344156

• Combining low-dose radiotherapy with sugemalimab, chemotherapy, and olaparib for treating advanced small-cell lung cancer

  This study is testing a new treatment plan that combines low-dose radiation, a drug called sugemalimab, chemotherapy, and another drug called olaparib to see if it helps people with advanced small-cell lung cancer.

  Recruiting Phase 1/2 Sichuan University · Chengdu, Sichuan · NCT06217757

• Combining Sunvozertinib with chemotherapy for advanced lung cancer after TKI failure

  This study is testing if combining a new drug called Sunvozertinib with chemotherapy can help people with advanced lung cancer who didn't respond to previous treatments.

  Recruiting Phase 1/2 Sichuan University · Chengdu, Sichuan · NCT06195189

• Combining low-dose radiation with immunotherapy and chemotherapy for lung cancer treatment

  This study is testing if adding low-dose radiation to standard chemotherapy and a new immune treatment can help people with advanced lung cancer feel better and live longer.

  Recruiting at 6 sites Phase 2 Sichuan University · Chongqing, Chongqing Municipality and 5 other locations · NCT06121505

• CAR-T therapy targeting CLDN18.2 and PD-L1 for advanced solid tumors

  This study is testing a new CAR-T therapy that targets specific proteins in patients with advanced solid tumors, like gastric and pancreatic cancers, who haven't responded well to other treatments.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT06084286

• Chidamide treatment to prevent leukemia recurrence after stem cell transplant

  This study is testing if a medication called chidamide can help prevent leukemia from coming back in patients with high-risk acute myeloid leukemia after they have a stem cell transplant.

  Recruiting Phase 1/2 Sichuan University · Chengdu, Sichuan · NCT05682755

• Dual-targeting CAR-T therapy for advanced cancer patients with pleural or peritoneal metastases

  This study is testing a new type of CAR-T therapy that targets specific proteins in advanced cancer patients with tumors in the pleural or peritoneal cavities to see if it helps them when other treatments haven't worked.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT05477927

• Personalized dendritic cell vaccine for advanced cancer after surgery

  This study is testing a personalized vaccine made from patients' own tumor cells to see if it can help people with advanced cancer feel better after surgery.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT04147078

Quick answers

How many clinical trials run by Sichuan University are recruiting right now?

29, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 11, Phase 1: 8, Phase 1/2: 4, Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →